Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

Mucosal immunity to poliovirus.

Ogra PL, Okayasu H, Czerkinsky C, Sutter RW.

Expert Rev Vaccines. 2011 Oct;10(10):1389-92. doi: 10.1586/erv.11.106.

PMID:
21988303
2.

Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission.

Okayasu H, Sutter RW, Czerkinsky C, Ogra PL.

Vaccine. 2011 Oct 26;29(46):8205-14. doi: 10.1016/j.vaccine.2011.08.059. Epub 2011 Sep 5. Review.

PMID:
21896299
3.

Mucosal decisions: tolerance and responsiveness at mucosal surfaces.

Russell MW, Ogra PL.

Immunol Invest. 2010;39(4-5):297-302. doi: 10.3109/08820131003729927. No abstract available.

PMID:
20450281
4.

Ageing and its possible impact on mucosal immune responses.

Ogra PL.

Ageing Res Rev. 2010 Apr;9(2):101-6. doi: 10.1016/j.arr.2009.07.007. Epub 2009 Aug 5. Review.

PMID:
19664726
5.

Developmental aspects of the mucosal immune system: role of external environment, mucosal microflora and milk.

Ogra PL.

Adv Exp Med Biol. 2009;639:41-56. doi: 10.1007/978-1-4020-8749-3_4. Review. No abstract available.

PMID:
19227533
6.

Concluding remarks. The Window of Opportunity: Pre-Pregnancy to 24 Months of Age.

Barker DJ, Bergmann RL, Ogra PL.

Nestle Nutr Workshop Ser Pediatr Program. 2008;61:255-60.

PMID:
18360965
7.

Effects of early environment on mucosal immunologic homeostasis, subsequent immune responses and disease outcome.

Ogra PL, Welliver RC Sr.

Nestle Nutr Workshop Ser Pediatr Program. 2008;61:145-81. doi: 10.1159/0000113492. Review.

PMID:
18196951
8.

Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses.

Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, Velozo L, Jafri H, Chavez-Bueno S, Ogra PL, McKinney L, Reed JL, Welliver RC Sr.

J Infect Dis. 2007 Apr 15;195(8):1126-36. Epub 2007 Mar 9.

PMID:
17357048
9.

Recent advances in otitis media. 6. Vaccine.

Giebink GS, Kurono Y, Bakaletz LO, Kyd JM, Barenkamp SJ, Murphy TF, Green B, Ogra PL, Gu XX, Patel JA, Heikkinen T, Pelton SI, Hotomi M, Karma P.

Ann Otol Rhinol Laryngol Suppl. 2005 Jan;194:86-103. Review. No abstract available.

PMID:
15700938
10.

Recent advances in otitis media. 5. Microbiology and immunology.

Barenkamp SJ, Kurono Y, Ogra PL, Leiberman A, Bakaletz LO, Murphy TF, Chonmaitree T, Patel JA, Heikkinen T, Sih TM, Hurst DS, St Geme JW 3rd, Kawauchi H, Stenfors LE.

Ann Otol Rhinol Laryngol Suppl. 2005 Jan;194:60-85. Review. No abstract available.

PMID:
15700937
11.

A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus.

Garofalo RP, Hintz KH, Hill V, Patti J, Ogra PL, Welliver RC Sr.

J Med Virol. 2005 Feb;75(2):282-9.

PMID:
15602730
12.

In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice.

Griffiths EA, Duffy LC, Schanbacher FL, Qiao H, Dryja D, Leavens A, Rossman J, Rich G, Dirienzo D, Ogra PL.

Dig Dis Sci. 2004 Apr;49(4):579-89.

PMID:
15185861
13.

Production of interferon gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18.

Garofalo RP, Hintz KH, Hill V, Ogra PL, Welliver RC Sr.

J Med Virol. 2004 Jun;73(2):289-94.

PMID:
15122806
14.

Respiratory syncytial virus: the virus, the disease and the immune response.

Ogra PL.

Paediatr Respir Rev. 2004;5 Suppl A:S119-26. Review.

PMID:
14980256
15.

Mucosal immunity: some historical perspective on host-pathogen interactions and implications for mucosal vaccines.

Ogra PL.

Immunol Cell Biol. 2003 Feb;81(1):23-33. No abstract available.

PMID:
12534943
16.

Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection.

Welliver RC, Garofalo RP, Ogra PL.

Pediatr Infect Dis J. 2002 May;21(5):457-61. No abstract available.

PMID:
12150192
17.

Recent advances in otitis media. 8. Diagnosis and screening.

Bellussi L, Dhooge I, Downs MP, Karma P, Marchisio P, Ogra PL, Passali D, Stewart IA, van Cauwenberge PB, Vernon-Feagans L.

Ann Otol Rhinol Laryngol Suppl. 2002 Mar;188:95-101. Review. No abstract available.

PMID:
11968865
18.

Recent advances in otitis media. 7. Vaccine.

Bakaletz LO, Barenkamp SJ, Eskola J, Green B, Gu XX, Harada T, Heikkinen T, Karma P, Klein JO, Kurono Y, Mogi G, Murphy TF, Ogra PL, Patel JA, Suzuki M, Yamanaka N.

Ann Otol Rhinol Laryngol Suppl. 2002 Mar;188:82-94. Review. No abstract available.

PMID:
11968864
19.

Recent advances in otitis media. 1. Definitions, terminology, and classification of otitis media.

Gates GA, Klein JO, Lim DJ, Mogi G, Ogra PL, Pararella MM, Paradise JL, Tos M.

Ann Otol Rhinol Laryngol Suppl. 2002 Mar;188:8-18. Review. No abstract available.

PMID:
11968863
20.

RSV, IgE, and wheezing.

Welliver RC, Ogra PL.

J Pediatr. 2001 Dec;139(6):903-5. No abstract available.

PMID:
11743524
21.

Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis.

Garofalo RP, Patti J, Hintz KA, Hill V, Ogra PL, Welliver RC.

J Infect Dis. 2001 Aug 15;184(4):393-9. Epub 2001 Jul 13.

PMID:
11471095
22.

Mucosal immunity and viral infections.

Freihorst J, Ogra PL.

Ann Med. 2001 Apr;33(3):172-7. Review.

PMID:
11370770
23.

Vaccination strategies for mucosal immune responses.

Ogra PL, Faden H, Welliver RC.

Clin Microbiol Rev. 2001 Apr;14(2):430-45. Review. Erratum in: Clin Microbiol Rev 2001 Jul;14(3):641.

24.

From chimpanzee coryza to palivizumab: changing times for respiratory syncytial virus.

Ogra PL.

Pediatr Infect Dis J. 2000 Aug;19(8):774-9; discussion 811-3. Review. No abstract available.

PMID:
10959757
25.

Mucosal immune response in the ear, nose and throat.

Ogra PL.

Pediatr Infect Dis J. 2000 May;19(5 Suppl):S4-8. Review. No abstract available.

PMID:
10821466
26.

Poliomyelitis as a paradigm for investment in and success of vaccination programs.

Ogra PL.

Pediatr Infect Dis J. 1999 Jan;18(1):10-5. Review. No abstract available.

PMID:
9951972
27.

Mucosal responses to parenteral and mucosal vaccines.

Kaul D, Ogra PL.

Dev Biol Stand. 1998;95:141-6. Review.

PMID:
9855424
28.

The role of the invariant chain in mucosal immunity.

Barrera CA, Almanza RJ, Ogra PL, Reyes VE.

Int Arch Allergy Immunol. 1998 Oct;117(2):85-93. Review.

PMID:
9784651
29.

Summary: recent developments in the immunology of otitis media.

Ogra PL.

Ann N Y Acad Sci. 1997 Dec 29;830:158-65. No abstract available.

PMID:
9616675
30.
31.

Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus.

Olszewska-Pazdrak B, Casola A, Saito T, Alam R, Crowe SE, Mei F, Ogra PL, Garofalo RP.

J Virol. 1998 Jun;72(6):4756-64.

32.

Rotavirus infection of cultured intestinal epithelial cells induces secretion of CXC and CC chemokines.

Casola A, Estes MK, Crawford SE, Ogra PL, Ernst PB, Garofalo RP, Crowe SE.

Gastroenterology. 1998 May;114(5):947-55.

PMID:
9558283
33.

Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism.

Olszewska-Pazdrak B, Pazdrak K, Ogra PL, Garofalo RP.

J Immunol. 1998 May 15;160(10):4889-95.

34.

Enhanced cytokine production by milk macrophages following infection with respiratory syncytial virus.

Sone S, Tsutsumi H, Takeuchi R, Matsuda K, Imai S, Ogra PL, Chiba S.

J Leukoc Biol. 1997 May;61(5):630-6.

PMID:
9129213
35.

Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells.

Saito T, Deskin RW, Casola A, Häeberle H, Olszewska B, Ernst PB, Alam R, Ogra PL, Garofalo R.

J Infect Dis. 1997 Mar;175(3):497-504.

PMID:
9041319
36.

Antigen presentation of mucosal pathogens: the players and the rules.

Reyes VE, Ye G, Ogra PL, Garofalo R.

Int Arch Allergy Immunol. 1997 Feb;112(2):103-14. Review.

PMID:
9030089
38.

Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha.

Garofalo R, Mei F, Espejo R, Ye G, Haeberle H, Baron S, Ogra PL, Reyes VE.

J Immunol. 1996 Sep 15;157(6):2506-13.

PMID:
8805651
39.

Morphologic and motility changes of nasal cilia in primary culture caused by Haemophilus influenzae.

Fujihara K, Yamanaka N, Bernstein JM, Ogra PL, Hard R.

Ann Otol Rhinol Laryngol. 1996 Jun;105(6):452-7.

PMID:
8638896
41.

Characteristics of IL-6 and TNF-alpha production by respiratory syncytial virus-infected macrophages in the neonate.

Matsuda K, Tsutsumi H, Sone S, Yoto Y, Oya K, Okamoto Y, Ogra PL, Chiba S.

J Med Virol. 1996 Feb;48(2):199-203.

PMID:
8835355
42.

An ultrastructural study of the interaction of human eosinophils with respiratory syncytial virus.

Kimpen JL, Garofalo R, Welliver RC, Fujihara K, Ogra PL.

Pediatr Allergy Immunol. 1996 Feb;7(1):48-53.

PMID:
8792384
43.

Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus.

Patel JA, Kunimoto M, Sim TC, Garofalo R, Eliott T, Baron S, Ruuskanen O, Chonmaitree T, Ogra PL, Schmalstieg F.

Am J Respir Cell Mol Biol. 1995 Nov;13(5):602-9.

PMID:
7576697
44.
45.
46.
47.

Respiratory syncytial virus infection: clinical presentation and management.

Patel JA, Deka K, Ogra PL.

Indian J Pediatr. 1995 Jan-Feb;62(1):25-32. Review.

PMID:
10829841
48.

Assessment of engraftment and function of human tonsillar and blood mononuclear cells in immunodeficient mice.

Albini B, Nadal D, Chen C, Schlapfer E, Mookerjee BK, Stulnig T, Ogra PL, Wick G, Cohen SA.

Adv Exp Med Biol. 1995;371A:85-9. Review. No abstract available.

PMID:
8526024
49.

Reduction of virus shedding by B. bifidum in experimentally induced MRV infection. Statistical application for ELISA.

Duffy LC, Zielezny MA, Riepenhoff-Talty M, Dryja D, Sayahtaheri-Altaie S, Griffiths E, Ruffin D, Barrett H, Ogra PL.

Dig Dis Sci. 1994 Nov;39(11):2334-40.

PMID:
7956600
50.

Treatment of respiratory syncytial virus infections in children.

Mäkelä MJ, Ruuskanen O, Ogra PL.

Ann Med. 1994 Oct;26(5):341-3. Review.

PMID:
7826594

Supplemental Content

Support Center